CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 137 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $56,000 | -76.8% | 14,928 | 0.0% | 0.00% | – |
| Q4 2015 | $241,000 | +53.5% | 14,928 | 0.0% | 0.00% | – |
| Q3 2015 | $157,000 | -72.2% | 14,928 | -33.3% | 0.00% | -100.0% |
| Q2 2015 | $564,000 | +171.2% | 22,392 | +200.0% | 0.00% | – |
| Q1 2015 | $208,000 | -75.4% | 7,464 | -83.9% | 0.00% | -100.0% |
| Q4 2014 | $844,000 | +770.1% | 46,423 | +522.0% | 0.00% | – |
| Q3 2014 | $97,000 | -65.6% | 7,464 | -65.2% | 0.00% | – |
| Q2 2014 | $282,000 | -42.1% | 21,450 | -35.7% | 0.00% | -100.0% |
| Q1 2014 | $487,000 | -90.8% | 33,359 | -83.7% | 0.00% | -90.0% |
| Q4 2013 | $5,299,000 | -7.6% | 204,238 | +26.2% | 0.01% | 0.0% |
| Q3 2013 | $5,736,000 | +60.3% | 161,893 | -29.4% | 0.01% | +42.9% |
| Q2 2013 | $3,578,000 | – | 229,182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |